{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:30:32Z","timestamp":1777613432984,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1067\/mjd.2002.126250","type":"journal-article","created":{"date-parts":[[2002,10,24]],"date-time":"2002-10-24T17:10:33Z","timestamp":1035479433000},"page":"789-791","source":"Crossref","is-referenced-by-count":124,"title":["Topical tacrolimus for repigmentation of vitiligo"],"prefix":"10.1067","volume":"47","author":[{"given":"Pearl E.","family":"Grimes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene T.","family":"Dytoc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.126250_bib1","first-page":"873","article-title":"Diseases of hypopigmentation","author":"Grimes","year":"1996"},{"key":"10.1067\/mjd.2002.126250_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0190-9622(86)70021-2","article-title":"T-cell profiles in vitiligo","volume":"14","author":"Grimes","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0190-9622(87)70243-6","article-title":"Natural cell-mediated cytotoxicity in vitiligo","volume":"17","author":"Ghoneum","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","article-title":"Autoantibodies in tyrosinase","volume":"79","author":"Fishman","year":"1997","journal-title":"Cancer"},{"key":"10.1067\/mjd.2002.126250_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3349\/ymj.1994.35.4.404","article-title":"Immunohistochemical studies from vitiligo?comparison between active and inactive lesions","volume":"35","author":"Ahn","year":"1994","journal-title":"Yonsei Med J"},{"key":"10.1067\/mjd.2002.126250_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0923-1811(98)00070-X","article-title":"Serum concentration of the soluble interleukin-2 receptor in vitiligo patients","volume":"19","author":"Yeo","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1067\/mjd.2002.126250_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1067\/mjd.2002.126250_bib8","first-page":"325","article-title":"Vitiligo: an overview of therapeutic approaches","volume":"11","author":"Grimes","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2002.126250_bib9","first-page":"534","article-title":"The effects of isoprinosine treatment on repigmentation and immunologic aberrations in vitiligo [abstract]","volume":"98","author":"Grimes","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-4362.1994.tb02903.x","article-title":"Effect of prolonged treatment with levamisole on vitiligo with limited and slow spreading disease","volume":"33","author":"Pasricha","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1346-8138.1998.tb02391.x","article-title":"Suplatast tosilate (IPD): a new immunoregulator is effective in vitiligo treatment","volume":"25","author":"Nihel","year":"1998","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-4362.1979.tb01924.x","article-title":"Cyclophosphamide and vitiligo","volume":"18","author":"Gokdale","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses: a clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-4362.1989.tb02517.x","article-title":"Vitiligo repigmentation with Anapsos (Polypodium leucotomos)","volume":"28","author":"Mohammad","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0738-081X(97)00132-6","article-title":"Non-PUVA nonsurgical therapies for vitiligo","volume":"15","author":"Mandel","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/1523-1747.ep12608217","article-title":"Melanogenesis from topical mechlorethamine and analogues in skin of hairless mice and in vitiligo","volume":"65","author":"VanScott","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archderm.136.8.999","article-title":"Safety and efficacy of one year of tacrolimus ointment monotherapy in adults with atopic dermatitis","volume":"136","author":"Reitamo","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.126250_bib18","first-page":"74","article-title":"Tacrolimus (FK 506) experience in dermatology","volume":"5","author":"Lawrence","year":"1998","journal-title":"Dermatol Ther"},{"key":"10.1067\/mjd.2002.126250_bib19","first-page":"654","article-title":"Topical triamcinolone and tacrolimus differ in their in vivo effects on Langerhans cells during the treatment of atopic dermatitis [abstract 788]","volume":"112","author":"Gordon","year":"1999","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202700170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202700170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T16:58:40Z","timestamp":1554397120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202700170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0190962202700170"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.126250","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}